PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-09-06

Date Title Company
06-Sep-2021 Evotec partner Bayer: Phase IIb trial shows eliapixant significantly decreases cough frequency in patients with refractory chronic cough Evotec
06-Sep-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Sep-2021 The Worldwide Healthcare Interoperability Market Report 2021 – InterSystems Corporation, Orion Health group of companies, Allscripts Healthcare LLC, Infor, Cerner Corporation, iNTERFACEWARE Inc The Wire Times
06-Sep-2021 Teeth Whitening Market Trajectory & Analytics, 2021 to 2027 – Johnson & Johnson Services, BRODIE & STONE, Procter & Gamble, GoSmile, LLC The Wire Times
06-Sep-2021 Global Healthcare Education Solutions Market (2021 to 2027) – by Product & Service, Technology, Application, End-user and Geography – Koninklijke Philips N.V., Siemens Healthcare Private Limited The Wire Times
06-Sep-2021 Cannovum AG starts European cannabis expansion with founding of Cannovum Iberia LDA Cannovum AG
06-Sep-2021 Medical Terminology Software Market Trends, Sales Analysis, SWOT Study & COVID 19 impact on Industry Share by 2027 The Wire Times
06-Sep-2021 Adenoids Market Supply, Growth Factors, Regional Outlook & Forecast till 2027 The Wire Times
06-Sep-2021 Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis Businesswire
06-Sep-2021 Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia Newron Pharmaceuticals SpA
06-Sep-2021 Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia Newron Pharmaceuticals S.p.A.